100 % Datengenauigkeit
Wissenschaftlicher Support rund um die Uhr
0 % Toleranz bei der Produktqualität
Lagerstandorte
- New Jersey, USA
- Czech Republic, EU
- Mumbai, India
* Vorbehaltlich Verfügbarkeit
Dokumentation
Enthält: HPLC, MASS/LC-MS, 1H-NMR, FT-IR, Gehalt, Structure Elucidation Report (SER) sowie zusätzliche analytische Daten je nach Produkt.
1640972-35-5Dihydro Tofacitinib Impurity
● Auf Lager
| Katalog-Nr.:: | VE008429 |
|---|---|
| CAS-Nr.:: | 1640972-35-5 |
| Summenformel:: | C16H22N6O |
| Molare Masse:: | 314.39 g/mol |
Zusätzliche Informationen zu CAS 1640972-35-5
Parent drug
TofacitinibIUPAC-Name
3-((3R, 4R)-3-((6, 7-dihydro-5H-pyrrolo [2, 3-d] pyrimidin-4-yl) (methyl) amino)-4-methylpiperidin-1-yl)-3-oxopropanenitrileSynonyme
5, 6-Dihydro TofacitinibBeschreibung
Angebot anfordern
„*“ zeigt erforderliche Felder an
Other products related to Tofacitinib impurities
Verunreinigungsstruktur
Name der Muttersubstanz
CAS-Nr.:
Name der Verunreinigung
Katalog-Nr.:
![N-methyl-N-(3R,4R)-(4-methyl-1-nitrosopiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine](https://veeprho.com/N-methyl-N-4-methyl-1-nitrosopiperidin-3-yl-7H-pyrrolo23-dpyrimidin-4-amine.jpeg "N-methyl-N-(3R,4R)-(4-methyl-1-nitrosopiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine")
Tofacitinib
CAS No. N/A
Cat No. VE009895
![5,7-dihydro-6H-pyrrolo [2,3-d] pyrimidin-6-one impurity](https://veeprho.com/wp-content/uploads/2022/09/5-7-dihydro-6H-pyrrolo-2-3-d-pyrimidin-6-one-impurity.png "5,7-dihydro-6H-pyrrolo [2,3-d] pyrimidin-6-one impurity")
Tofacitinib
CAS No. 5817-96-9
Cat No. VE0010061
![3-(4-methyl-3-(methyl(7-nitroso-7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile](https://veeprho.com/wp-content/uploads/2022/08/3-4-methyl-3-methyl-7-nitroso-7H-pyrrolo-2-3-d-pyrimidin-4-yl-amino-piperidin-1-yl-3-oxopropanenitri.png "3-(4-methyl-3-(methyl(7-nitroso-7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile")
Tofacitinib
CAS No. N/A
Cat No. VE009894
![4-chloro-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidine](https://veeprho.com/wp-content/uploads/2022/08/4-chloro-6-7-dihydro-5H-pyrrolo-2-3-d-pyrimidine.png "4-chloro-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidine")
![N-methyl-N-((3S,4S)-4-methyl-1-nitrosopiperidin-3-yl)-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-amine](https://veeprho.com/wp-content/uploads/2023/02/N-methyl-N-3S-4S-4-methyl-1-nitrosopiperidin-3-yl-6-7-dihydro-5H-pyrrolo-2-3-d-pyrimidin-4-amine.png "N-methyl-N-((3S,4S)-4-methyl-1-nitrosopiperidin-3-yl)-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-amine")
Tofacitinib
CAS No. N/A
N-methyl-N-((3S,4S)-4-methyl-1-nitrosopiperidin-3-yl)-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-amine
Cat No. VE0011034
![Butyl 4-cyano-3-imino-5-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-5-oxopentanoate](https://veeprho.com/wp-content/uploads/2022/11/Butyl-4-cyano-3-imino-5-3R-4R-4-methyl-3-methyl-7H-pyrrolo-2-3-d-pyrimidin-4-yl-amino-piperidin-1-yl-5-oxopentanoate.png "Butyl 4-cyano-3-imino-5-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-5-oxopentanoate")
Tofacitinib
CAS No. N/A
Cat No. VE0010254
Tofacitinib
CAS No. N/A
Cat No. VE0010540